Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Allan B. Dietz and his lab are focused on getting novel therapies to patients. As co-director of the Human Cellular Therapy Lab within Mayo Clinic's Center for Regenerative Biotherapeutics, Dr. Dietz focuses on the use of cells as drugs.
Dr. Dietz's lab supports these trials by developing methods to grow and characterize these cells; characterizing patients' immune status; and monitoring therapy-induced changes in that status. During the course of these studies Dr. Dietz and his colleagues have described the immunosuppressive effects of monocytes and seek to understand their generation and consequence.
Dr. Dietz's lab is responsible for developing new therapies for patients. These include adult stem cell treatments and cancer vaccines. Dr. Dietz and his colleagues are dedicated to developing new treatments for the patients with some of the most devastating diseases. These are often the first times these treatments have been used in patients. The lab works with clinicians to get the required approval from the FDA and internal Mayo regulatory bodies.
Learn about clinical trials that address specific scientific questions about human health and disease.
See my studies.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Review my research fingerprint, network, grants, projects, publications, Scopus profile, and Altmetrics scores and badges.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.